Evaluation of the Abbott RealTime HBV DNA assay and comparison to the Cobas AmpliPrep/Cobas TaqMan 48 assay in monitoring patients with chronic cases of hepatitis B
- PMID: 18272717
- PMCID: PMC2292927
- DOI: 10.1128/JCM.02046-07
Evaluation of the Abbott RealTime HBV DNA assay and comparison to the Cobas AmpliPrep/Cobas TaqMan 48 assay in monitoring patients with chronic cases of hepatitis B
Abstract
The new Abbott RealTime hepatitis B virus (HBV) assay was compared to the Cobas AmpliPrep/Cobas TaqMan assay with 128 serum samples from patients with chronic hepatitis B. There was an excellent correlation (r = 0.961) between the two assays, with the Abbott RealTime test showing at least equivalent sensitivity and a slightly wider dynamic range than the Cobas TaqMan assay. By coupling high sensitivity with a large dynamic range, the Abbott RealTime HBV assay is useful in monitoring the response to antiviral therapy.
Figures
References
-
- Chen, R. W., H. Piiparinen, M. Seppanen, P. Koskela, S. Sarna, and M. Lappalainen. 2001. Real-time PCR for detection and quantitation of hepatitis B virus DNA. J. Med. Virol. 65250-256. - PubMed
-
- Ganem, D., and A. M. Prince. 2004. Hepatitis B virus infection: natural history and clinical consequences. N. Engl. J. Med. 3501118-1129. - PubMed
-
- Gibosn, U. E., C. A. Heid, and P. M. Williams. 1996. A novel method for real time quantitative real-time PCR. Genomes Res. 6995-1001. - PubMed
-
- Hochberger, S., D. Althof, R. Gallegos de Schrott, N. Nachbaur, H. Rock, and H. Leying. 2006. Fully automated quantitation of hepatitis B virus (HBV) DNA in human plasma by the COBAS TaqMan system. J. Clin. Virol. 35373-380. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
